Axon Therapies Announces Positive Early Clinical Data from REBALANCE-HF Randomized Clinical Trial
Late-breaking results presented at the European Society of Cardiology's Heart Failure Association annual conference and simultaneously published online in the European Journal of Heart Failure
United States Northwestern University Sanjiv Shah York Heart Association National Principal Investigator Feinberg School Of Medicine
Source: dicardiology.com